Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

548.00p
   
  • Change Today:
    -20.00p
  • 52 Week High: 1,545.00
  • 52 Week Low: 130.00
  • Currency: UK Pounds
  • Shares Issued: 5.92m
  • Volume: 12,666
  • Market Cap: £32.43m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £1,028,744
Vladislav Sandler Ph.D. 103,862 £569,164
Peter Redmond 13,991 £76,671

Major Shareholders

Notifier** Holding Value*
David John Smith 399,478 £2,189,139
Alexis Sandler 187,726 £1,028,738
Dr Vladislav Sandler 103,862 £569,164
Optiva Securities Limited 70,329 £385,403
Flascherberg Capital Anstalt 69,991 £383,551
Craig Auringer 59,593 £326,570
HSBC Client Holdings Nominee (UK) Limited 45,160 £247,477
Ron Valk 42,828 £234,697
Samantha Bauer 42,706 £234,029
Plum Capital 29,232 £160,191
43 North LLC 28,429 £155,791
Abdelatif LACHAB 6,500 £35,620
Wayne Gibson 6,500 £35,620

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 548.00p
Change Today -20.00p
% Change -3.52 %
52 Week High 1,545.00
52 Week Low 130.00
Volume 12,666
Shares Issued 5.92m
Market Cap £32.43m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 05-Jan-2026

Time Volume / Share Price
16:35 1,630 @ 548.00p
16:35 71 @ 548.00p
16:35 362 @ 548.00p
16:35 246 @ 548.00p
16:35 500 @ 548.00p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page